National Right to Life Praises Members of Congress for Urging Enforcement of FDA Rules Regarding Mifepristone Abortions
WASHINGTON, D.C.— Today, National Right to Life (NRLC) praised action by a bicameral group of pro-life Senators and Members of Congress urging “robust enforcement” of the Risk Evaluation and Mitigation Strategy (REMS) concerning the mifepristone (RU-486) abortion drug process. In a letter sent to FDA Commissioner Stephen Hahn, M.D., and sponsored by U.S. Senator Cindy Hyde-Smith (R-Miss.), […]